INS and obstructive sleep apnea syndrome: Medications with potential effects on insulin sensitivity and carbohydrate metabolism (statin, beta–blocker, sartan, calcium antagonist, diuretics, hydrochlorothiazide, angiotensin-converting-enzyme inhibitor) showed no significant difference between OSA and non OSA groups.